With the market having a volatile few months, below is a list of the top 10 mid-cap stocks ranked by their Year-To-Date performance. The list includes companies from sectors such as semiconductor ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

In this article, we will be taking a look at the 20 Best Biotech Stocks Under $20 to Buy Now. The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of ...

Krystal Biotech pioneered the first topical gene therapy. ARS Pharmaceuticals introduced the first needle-free therapy to treat anaphylaxis. Both therapies have blockbuster potential. In 2023, Krystal ...

Three biotech stocks in the IBD 50 are setting up in bases while a fourth is pulling back from highs as the first-quarter earnings season gets into full swing. Travere TherapeuticsTVTX, part of IBD's ...

TheFly reported on May 13 that BIOA received newly initiated coverage with a Buy rating and a $40 price target by BITG.

State Street SPDR S&P Biotech ETF (XBI) gained +40.32% over the past year and equally weights roughly 145 stocks to provide exposure to smaller biotech companies. iShares Biotechnology ETF (IBB) ...

Here are the latest stock prices and performance trends of pharmaceuticals and health care companies. You can find the latest news and analysis on pharmaceuticals and health care stocks here.

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC's Halftime Report this week about large-cap biotech: "These are growth stocks where you don't have to worry about disruption ...

Biotech stocks saw a major rebound in 2025, with key indexes significantly outperforming the S&P 500. Private investment in longevity science doubled in 2024, highlighting growing interest in ...